Category Archives: Cell Medicine

Cryo-Save Hires Stem Cell Expert in the Flagship Lab in Niel, Belgium

ZUTPHEN, the Netherlands, April 24, 2012 /PRNewswire/ — In line with its continuous efforts to improve internal stem cell procedures, Cryo-Save proudly announces the appointment of the highly knowledgeable stem cell expert Dr. Marcin Jurga. Dr Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , , , | Comments Off

Cell Therapeutics Enters into Agreement to Acquire Pacritinib, a Novel Highly Selective JAK2 Inhibitor Phase 3 …

SEATTLE and SINGAPORE, April 19, 2012 /PRNewswire/ — Cell Therapeutics, Inc.(“CTI”) (Nasdaq and MTA: CTIC) and S*BIO Pte Ltd announced today that the companies have entered into an asset purchase agreement pursuant to which CTI would acquire world-wide rights to S*BIO’s pacritinib, a highly selective JAK2 inhibitor. Pacritinib is an oral JAK2 (Janus Associated Kinase 2) selective inhibitor that has demonstrated encouraging clinical benefit in phase 1 and 2 clinical studies in patients with primary myelofibrosis (MF) or MF secondary to other myeloproliferative neoplasms (MPN). Pacritinib has orphan drug designation in the U.S. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , , | Comments Off

Inform Genomics Announces Results of Study Predicting Risk of Oral Mucositis in Patients Undergoing High Dose …

BOSTON–(BUSINESS WIRE)– Inform Genomics, Inc., a private company focused on developing novel platforms of personalized medicine products for cancer supportive care and inflammatory diseases, today announced the completion of the first phase of product development to predict a patients risk of developing oral mucositis after receiving high dose chemotherapy prior to hematopoietic stem cell transplant. The results of this single center, 153-patient study demonstrated the products ability to discriminate which patients develop oral mucositis with 99.3% accuracy and an area under the Receiver Operator Characteristic (ROC) curve of 99.7%. Further development will include validation of these initial results in a multicenter study. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , , , , | Comments Off

Autologous bone marrow-derived mononuclear cell transplants can reduce diabetic amputations

Public release date: 18-Apr-2012 [ | E-mail | Share ] Contact: David Eve celltransplantation@gmail.com Cell Transplantation Center of Excellence for Aging and Brain Repair Tampa, Fla. (April. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , | Comments Off

Stem cell institute to work with foreign agencies

California’s $3 billion stem cell agency, now more than 7 years old, has joined research partnerships with science and health agencies in eight foreign countries, the San Francisco institute announced. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , | Comments Off

Vatican’s Stem-Cell Censorship Sham

The Catholic Church has never had a particularly easy relationship with science. After all, this is the institution that sentenced Galileo Galilei as a heretic for his theories on the universe during the Roman Inquisition. Two thousand years later, the church forgave Galileo and called the whole misunderstanding a tragic mutual incomprehension but it remains safe to say the Vatican doesnt have a great track record when it comes to empirical open-mindedness Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , , | Comments Off

Advanced Cell Technology and PharmAthene Poised to Benefit From Positive Legislation

NEW YORK, NY–(Marketwire -03/28/12)- Biotechnology stocks have been on an impressive run this year as favorable legislation out of Washington is allowing biotech companies of all sizes to more easily navigate regulations. Five Star Equities examines the outlook for companies in the Biotechnology industry and provides equity research on Advanced Cell Technology Inc. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , | Comments Off

Research and Markets: Progenitor and Stem Cell Technologies and Therapies Reviews the Range Of Progenitor and Stem …

DUBLIN–(BUSINESS WIRE)– Dublin – Research and Markets (http://www.researchandmarkets.com/research/2fee68d4/progenitor_and_ste) has announced the addition of Woodhead Publishing Ltd’s new book “Progenitor and Stem Cell Technologies and Therapies” to their offering. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , | Comments Off

Advances in regenerative medicine spark skin cell banking startup

Weve heard of people freezing their eggs, blood and stem cells for use later on, but a health service startup is now enabling patients to freeze their own skin cells for potential future use in diagnostics, therapeutics and regenerative medicine techniques. Next Healthcare Inc.s goal is to enable personalized healthcare by providing skin and stem cell banking directly to patients through their medical professional Continue reading

Posted in Cell Medicine | Tagged , , , , , , , | Comments Off

California's stem cell agency ponders a future without taxpayer support

LOS ANGELES, Calif. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , | Comments Off